WallStreetZenWallStreetZen

NASDAQ: AIDX
20/20 Biolabs Revenue

OverviewForecastEarningsRevenue
DividendOwnership
20/20 Biolabs revenue was N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $353.4k, down 34.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AIDX annual revenue was $2.0M, with 16.7% growth year-over-year.

AIDX revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when AIDX announces revenue.

AIDX Revenue History By Year

AIDX Yearly RevenueAIDX RevenueAIDX ChangeAIDX Revenue Growth
2025-12-31$2.05M$292.79k+16.71%
2024-12-31$1.75M$328.04k+23.03%
2023-12-31$1.42MN/AN/A

1 of 1

20/20 Biolabs Revenue FAQ

What was AIDX's revenue last quarter?

20/20 Biolabs (NASDAQ: AIDX) reported Q1 2026 revenue of $353.38 thousand up 36.19% year over year. In the same quarter last year, 20/20 Biolabs's revenue was $553.82 thousand.

What was 20/20 Biolabs's revenue in 2025?

20/20 Biolabs's annual revenue for the twelve months ending Dec 31, 2025 was $2.05 million, a 16.71% increase year over year.

How much does 20/20 Biolabs make in a day?

Based on 20/20 Biolabs annual revenue for the past two years, AIDX makes an average of $5,202.02 per day.

What was 20/20 Biolabs's annual revenue growth in the past year?

As of Q2 2026, 20/20 Biolabs's revenue has grown null year over year. 20/20 Biolabs's revenue in the past year totaled N/A.

How much does 20/20 Biolabs make in a year?

20/20 Biolabs's revenue by year for the past two years is:
  • 20/20 Biolabs's revenue for the twelve months ending Dec 31, 2025 was $2.05 million, a 16.71% increase year over year.
  • 20/20 Biolabs's annual revenue for Dec 31, 2024 was $1.75 million, a 23.03% increase from 2023.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.